UPDATE 2-Amicus Therapeutics receives U.S. approval for Fabry disease drug
August 10, 2018 at 17:50 PM EDT
U.S. health regulators on Friday approved Amicus Therapeutics' Galafold, the first oral therapy to treat Fabry disease, a rare, sometimes fatal condition in which accumulation of fat damages several organs.
